PIAS3 negatively regulates RANKL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblasts.
about
MicroRNAs in multiple myeloma and related bone diseaseMethylsulfonylmethane Inhibits RANKL-Induced Osteoclastogenesis in BMMs by Suppressing NF-κB and STAT3 ActivitiesSTAT3 controls the neutrophil migratory response to CXCR2 ligands by direct activation of G-CSF-induced CXCR2 expression and via modulation of CXCR2 signal transductionPeroxiredoxin II negatively regulates lipopolysaccharide-induced osteoclast formation and bone loss via JNK and STAT3Transcriptional activity of erythroid Kruppel-like factor (EKLF/KLF1) modulated by PIAS3 (protein inhibitor of activated STAT3).Inactivation of glycogen synthase kinase-3β is required for osteoclast differentiation.Donepezil prevents RANK-induced bone loss via inhibition of osteoclast differentiation by downregulating acetylcholinesteraseGene associated with retinoid-interferon-induced mortality 19 attenuates murine autoimmune arthritis by regulation of th17 and treg cells.Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts.The paired-box homeodomain transcription factor Pax6 binds to the upstream region of the TRAP gene promoter and suppresses receptor activator of NF-κB ligand (RANKL)-induced osteoclast differentiation.Elevated Response to Type I IFN Enhances RANKL-Mediated Osteoclastogenesis in Usp18-Knockout Mice.
P2860
Q26770478-93C9FAE8-354F-4524-9A7C-3F1C72109907Q28552847-E57FC669-D007-41D0-91A1-E6D2B2E086F4Q33806040-293B776F-FB77-49D7-BE3D-3B1087FD0E17Q34729815-E430F152-CB6D-4FA7-B262-97EC2BF8B85FQ35352181-5700639E-30A0-4D96-81A5-5A46923757A8Q35604256-4C590DF9-E727-44C6-AB29-9AD5DF247F8DQ37082335-F0AB2FC6-D25E-4AF8-8FD4-FAFCF0A426CCQ38441012-3CB683ED-8D7D-4A1D-A7F9-8FCFB1BF73C5Q38854653-4B2108F8-0D68-4C0F-AEB2-F122ED544278Q42905527-81ABB537-0EA3-4633-9986-8F7A6585F708Q45948743-2A85E9D8-0840-4A7F-886D-5B7F67383F1F
P2860
PIAS3 negatively regulates RANKL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblasts.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
PIAS3 negatively regulates RAN ...... nd indirectly via osteoblasts.
@ast
PIAS3 negatively regulates RAN ...... nd indirectly via osteoblasts.
@en
type
label
PIAS3 negatively regulates RAN ...... nd indirectly via osteoblasts.
@ast
PIAS3 negatively regulates RAN ...... nd indirectly via osteoblasts.
@en
prefLabel
PIAS3 negatively regulates RAN ...... nd indirectly via osteoblasts.
@ast
PIAS3 negatively regulates RAN ...... nd indirectly via osteoblasts.
@en
P2093
P2860
P1433
P1476
PIAS3 negatively regulates RAN ...... and indirectly via osteoblasts
@en
P2093
Akihiko Yoshimura
Akihiro Hakozaki
Hironari Takaishi
Hiroshi Asahara
Jiro Takito
Masahito Matsumoto
Mitsuru Furukawa
Riko Nishimura
Sakamuri V Reddy
Shinichi Uchikawa
P2860
P304
P356
10.1182/BLOOD-2008-06-162594
P407
P577
2008-10-24T00:00:00Z